Increased inflammatory responsiveness of peripheral blood mononuclear cells (PBMCs) to in vitro NOD2 ligand stimulation in patients with ankylosing spondylitis

References

• Hanson A, Brown MA. Genetics and the causes of ankylosing spondylitis. Rheum Dis Clin North Am. 2017;43:401–414.
   PubMed Web of Science ®Google Scholar
• Smith JA. Update on ankylosing spondylitis: current concepts in pathogenesis. Curr Allergy Asthma Rep. 2015;15:489.
   PubMed Web of Science ®Google Scholar
• Brown MA, Kennedy LG, Macgregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40:1823–1828.
   PubMed Web of Science ®Google Scholar
• Brown MA, Laval SH, Brophy S, et al. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000;59:883–886.
   PubMed Web of Science ®Google Scholar
• Reveille JD, Sims A-M, Danoy P, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet. 2010;42:123–127.
   PubMed Web of Science ®Google Scholar
• Cortes A, Hadler J, Pointon JP, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45:730–738.
   PubMed Web of Science ®Google Scholar
• Tsui FW, Tsui HW, Akram A, et al. The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis. Appl Clin Genet. 2014;7:105–115.
   PubMedGoogle Scholar
• O’Rielly DD, Uddin M, Rahman P. Ankylosing spondylitis: beyond genome-wide association studies. Curr Opin Rheumatol. 2016;28:337–345.
   PubMed Web of Science ®Google Scholar
• Smith JA, Colbert RA. The IL-23/IL-17 axis in spondyloarthritis pathogenesis: th17 and beyond. Arthritis Rheumatol (Hoboken, NJ). 2014;66:231–241.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805–820.
   PubMed Web of Science ®Google Scholar
• Motta V, Soares F, Sun T, et al. NOD-like receptors: versatile cytosolic sentinels. Physiol Rev. 2015;95:149–178.
   PubMed Web of Science ®Google Scholar
• Moreira LO, Zamboni DS. NOD1 and NOD2 signaling in infection and inflammation. Front Immun. 2012;3:328.
   PubMed Web of Science ®Google Scholar
• Stetson DB, Medzhitov R. T Helper 17 cells get the NOD. Immunity. 2007;27:546–548.
   PubMed Web of Science ®Google Scholar
• van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity. 2007;27:660–669.
   PubMed Web of Science ®Google Scholar
• Linden SVD, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–368.
   PubMed Web of Science ®Google Scholar
• Garrett S, T, Jenkinson LG, Kennedy H, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21:2286–2291.
   PubMed Web of Science ®Google Scholar
• Calin A, S, Garrett H, Whitelock LG, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21:2281–2285.
   PubMed Web of Science ®Google Scholar
• Doward L, Spoorenberg A, Cook S, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis. 2003;62:20–26.
   PubMed Web of Science ®Google Scholar
• 19. Li J, Moran T, Swanson E, et al. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet. 2004;13:1715–1725.
   PubMed Web of Science ®Google Scholar
• van der Meer JHM, Netea MG, Dinarello CA. Modulation of muramyl dipeptide stimulation of cytokine production by blood components. Clin Exp Immunol. 2009;156:428–433.
   PubMed Web of Science ®Google Scholar
• Hedl M, Abraham C. Nod2-induced autocrine interleukin-1 alters signaling by ERK and p38 to differentially regulate secretion of inflammatory cytokines. Gastroenterology. 2012;143:1530–1543.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101–1108.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Barr MJ, Lukens JR, et al. Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity. Immunity. 2011;34:75–84.
   PubMed Web of Science ®Google Scholar
• Vieira SM, Cunha TM, Franca RFO, et al. Joint NOD2/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis. J Immunol. 2012;188:5116–5122.
   PubMed Web of Science ®Google Scholar
• Rosenzweig HL, Martin TM, Jann MM, et al. NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis. Invest Ophthalmol Vis Sci. 2008;49:1518–1524.
   PubMed Web of Science ®Google Scholar
• Rosenzweig HL, Galster KT, Planck SR, Rosenbaum JT. NOD1 expression in the eye and functional contribution to IL-1beta-dependent ocular inflammation in mice. Invest Ophthalmol Vis Sci. 2009;50:1746–1753.
   PubMed Web of Science ®Google Scholar
• Joosten LAB, Heinhuis B, Abdollahi-Roodsaz S, et al. Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis. PNAS. 2008;105:9017–9022.
   PubMed Web of Science ®Google Scholar
• Magalhaes JG, Lee J, Geddes K, et al. Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands. Eur J Immunol. 2011;41:1445–1455.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Inohara N, Hernandez LD, et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 2002;416:194–199.
   PubMed Web of Science ®Google Scholar
• Tigno-Aranjuez JT, Abbott DW. Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease. Biochim Biophys Acta. 2012;1823:2022–2028.
   PubMed Web of Science ®Google Scholar
• Windheim M, Lang C, Peggie M, et al. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem J. 2007;404:179–190.
   PubMed Web of Science ®Google Scholar
• Hsu L-C, Ali SR, McGillivray S, et al. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci USA. 2008;105:7803–7808.
   PubMed Web of Science ®Google Scholar
• Marina-Garcia N, Franchi L, Kim Y-G, et al. Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation. J Immunol. 2009;182:4321–4327.
   PubMed Web of Science ®Google Scholar
• Nakamura N, Lill JR, Phung Q, et al. Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature. 2014;509:240–244.
   PubMed Web of Science ®Google Scholar
• Duan R, Leo P, Bradbury L, et al. Gene expression profiling reveals a downregulation in immune-associated genes in patients with AS. Ann Rheum Dis. 2010;69:1724–1729.
   PubMed Web of Science ®Google Scholar
• Hitotsumatsu O, Ahmad R-C, Tavares R, et al. The ubiquitin-editing enzyme a20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity. 2008;28:381–390.
   PubMed Web of Science ®Google Scholar
• Hammer GE, Turer EE, Taylor KE, et al. Dendritic cell expression of A20 preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol. 2011;12:1184–1193.
   PubMed Web of Science ®Google Scholar